Dr. Arrick is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1 Medical Center Dr
Dhmc. Department Of Medicine
Lebanon, NH 03756Phone+1 603-653-6181
Summary
- Bradley Arrick, MD, is an experienced Oncologist located in Lebanon, NH, specializing in cancer genetics. An alumnus of Weill Cornell Medicine and Harvard, he completed his residency at the University of California (San Diego) and fellowship at University of California (San Francisco). Dr. Arrick holds a pivotal role as a Clinical Professor at Dartmouth-Hitchcock Physicians since 1990. He has numerous publications to his credit in esteemed journals like Breast Cancer Research and Treatment, Medical Decision Making, and Journal of Cellular Biochemistry. His exemplary work in the medical field has earned him honors such as the New Hampshire Top Docs in 2020 and CMS Meaningful Use Stage 1 Certification in 2011 and 2013.
Education & Training
HarvardMHCM, Healthcare Management, 2015 - 2017
University of California (San Francisco)Fellowship, Hematology and Medical Oncology, 1994 - 1997
University of California (San Diego) Medical CenterResidency, Internal Medicine, 1984 - 1987
Weill Cornell MedicineClass of 1984- Rockefeller UniversityPhD, 1977 - 1983
Certifications & Licensure
NH State Medical License 1990 - 2026
CA State Medical License 1985 - 2023
VT State Medical License 2014 - 2020
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- New Hampshire Top Docs 2020
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011, 2013
Publications & Presentations
PubMed
- 1 citationsAlternating 17β-Estradiol and Aromatase Inhibitor Therapies Is Efficacious in Postmenopausal Women with Advanced Endocrine-Resistant ER+ Breast Cancer.Gary N Schwartz, Peter A Kaufman, Karthik V Giridhar, Jonathan D Marotti, Mary D Chamberlin
Clinical Cancer Research. 2023-08-01 - 1 citationsPlasma DNA as a "liquid biopsy" incompletely complements tumor biopsy for identification of mutations in a case series of four patients with oligometastatic breast can...Mary D. Chamberlin, Jason D. Wells, Kevin Shee, Jennifer R. Bean, Jonathan D. Marotti
Breast Cancer Research and Treatment. 2020-06-19 - 7 citationsVisual Representations of Risk Enhance Long-Term Retention of Risk Information: A Randomized Trial.Bradley A. Arrick, Katarzyna Bloch, Laura Stein Colello, Steven Woloshin, Lisa M. Schwartz
Medical Decision Making. 2019-01-11
Journal Articles
- Visual representations of risk enhance long-term retention of risk information: A randomized trialBradley Arrick, Katarzyna Bloch, Laura Colello, Steven Woloshin, Lisa Schwartz, Medical Decision Making, 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
